1859
Latest round
- Series A
Last raised
- Nov 2021
Total raised
- $40M
Investors
- 4
About 1859
Based in San Diego, CA, US, and founded in 2019 by Devon Cayera and Andrew MacConnell, 1859, Inc. is a biotechnology company focusing on the discovery and development of next-generation therapeutics. In February 2022, 1859, Inc. The company's platform helps in creating new medicine, enabling scientists to parallelize the discovery of new medicines by combining datasets generated from pico-scale screening of novel chemical libraries with artificial intelligence predictions. 1859, Inc.
Who invested in 1859
4 investors across 1 round
See all investors in 1859
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 17, 2021
Amount
$40M
Investors
Questions about 1859
Who invested in 1859?
1859 has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has 1859 raised?
1859 has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did 1859 last raise money?
1859's most recent round on record is a Series A, in Nov 2021.
What does 1859 do?
Based in San Diego, CA, US, and founded in 2019 by Devon Cayera and Andrew MacConnell, 1859, Inc.
Where is 1859 headquartered?
1859 is headquartered in San Diego, US.
Which VCs invest in companies like 1859?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at 1859's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like 1859? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.